Combination Effect of Novel Bimetallic Ag-Ni Nanoparticles with Fluconazole against Candida albicans

Majid Rasool Kamli1,2, Elham A Alzahrani3, Soha M Albukhari3

  • 1Department of Biological Sciences, Faculty of Sciences, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia.

Insights

Silver-nickel nanoparticles (Ag-Ni NPs) show potent antifungal activity against drug-resistant Candida albicans. These nanoparticles synergize with fluconazole, disrupt biofilms, and block efflux pumps, offering a novel approach to combatting resistant fungal infections.

Area of Science:

  • Nanotechnology
  • Mycology
  • Biochemistry

Background:

  • Antifungal drug resistance in Candida species, particularly Candida albicans, presents a significant global health challenge.
  • Combinations of transition and noble metals have demonstrated synergistic antimicrobial effects.
  • Salvia officinalis leaf extract can be utilized for biogenic synthesis of metal nanoparticles.

Purpose of the Study:

  • To synthesize silver-nickel bimetallic nanoparticles (Ag-Ni NPs) using Salvia officinalis leaf extract.
  • To evaluate the antifungal activity of Ag-Ni NPs, alone and in combination with fluconazole (FLZ), against FLZ-resistant Candida albicans.
  • To investigate the impact of Ag-Ni NPs on Candida albicans membrane integrity, efflux pumps, and biofilm formation.

Main Methods:

  • One-pot seedless biogenic synthesis of Ag-Ni NPs using Salvia officinalis aqueous leaf extract.
  • Characterization of Ag-Ni NPs using UV-vis, FTIR, XRD, SEM, EDX, and TGA.
  • Antifungal susceptibility testing (MIC, MFC), synergy testing (FICI), membrane integrity assays, efflux pump assays (rhodamine 6G), and biofilm inhibition assays.

Main Results:

  • Ag-Ni NPs exhibited potent antifungal activity against fluconazole-resistant Candida albicans with MIC of 1.56 μg/mL and MFC of 3.12 μg/mL.
  • A synergistic interaction was observed between Ag-Ni NPs and fluconazole (FICI = 0.31).
  • Ag-Ni NPs disrupted membrane integrity, inhibited biofilm formation at higher concentrations, halted morphological transition at lower concentrations, and blocked efflux pumps in resistant strains.

Conclusions:

  • Biogenically synthesized Ag-Ni NPs demonstrate significant antifungal efficacy against drug-resistant Candida albicans.
  • Ag-Ni NPs show synergistic effects with fluconazole and possess multi-modal mechanisms of action, including biofilm disruption and efflux pump inhibition.
  • Ag-Ni NPs represent a promising therapeutic candidate for combating infections caused by multi-drug resistant Candida strains.